Cargando…

DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer

To investigate the prognostic value of DGM-CM6 (Distant Genetic Model-Clinical variable Model 6) for endocrine-responsive breast cancer (ERBC) patients, we analyzed 752 operable breast cancer patients treated in a Taiwan cancer center from 2005 to 2014. Among them, 490 ERBC patients (identified by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Lei, Wang, Xiao-Jia, Mo, Yin-Yuan, Cheng, Skye Hung-Chun, Zhou, Yunyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263173/
https://www.ncbi.nlm.nih.gov/pubmed/32528885
http://dx.doi.org/10.3389/fonc.2020.00783